Research On Drug Retail Network Models In China

In recent years, information technology becomes constantly mature and sales network becomes increasingly fierce. Goldman Sachs forecasted that the global network sales scale in2013would reach＄963,000,000,000, with an average annual growth rate of nearly20%. However, China electronic commerce research center showed that online retail market transaction scale has reached￥513.1,000,000,000in2010. At present, sales network has spread to various fields, including pharmaceutical industry as well.The important issue, seeing a doctor difficultly and expensively, has been faced by ordinary people. The government adopted a variety of management means, which had accomplished so little. From the current view, drug network sales development trends gradually clear. It greatly reduces the circulation link and the medical cost, and is helpful for pharmaceutical enterprises in its own profit at the lower drug price. So it will be a hopeful way to reasonable control the network channels, and guide the healthy development for the current medical problems. This paper will be a comprehensive comparison of between the United States and China about the medical network sales development situation, and its factors, in order to give some ideas and suggestions for China future drug B2C marketing mode development.This paper is divided into five chapters. The first chapter introduces the research background, purpose, significance, research content, research design and process. The second chapter of literature review is mainly to review our country electronic commerce and pharmaceutical marketing channel development history. The third chapter makes a comparison between the United States and China about the medical network sales development situation, chooses two typical pharmaceutical retail enterprises as cases, describes and analyses the medical network marketing business origin, business model, achievement, etc. The fourth chapter mainly compares medical network marketing influencing factors in China and the U.S., and finds opportunities and shortages of future medical network marketing development in China. The last chapter is of conclusion and suggestion, and is divided into two parts. One is to summarize above, to induce necessity and feasibility of domestic medicine retail network, and to puts forward some proposals and measures.The other one is to point out the limitations on the research content and method, and research prospects for the future drug network marketing.